Update shared on 03 Nov 2025
Fair value Increased 6.65%Analysts have increased their price target for SHAPE Australia from $5.27 to $5.62. They cite higher projected revenue growth and improved profit margins as key drivers behind the upward revision.
What's in the News
- SHAPE Australia is actively seeking mergers and acquisition opportunities as part of its growth strategy. The company has appointed Peter Massey to the Board for his significant M&A experience to strengthen this focus (Key Developments).
- The company announced a fully franked ordinary dividend of AUD 0.125 per share for the six months ended June 30, 2025. The ex-date is set for August 29, 2025, with the record date on September 1, 2025, and payment on September 15, 2025 (Key Developments).
Valuation Changes
- Fair Value has increased from A$5.27 to A$5.62, reflecting a moderately improved outlook.
- Discount Rate has edged up slightly from 7.81% to 7.83%.
- Revenue Growth projections have risen from 5.79% to 6.76%.
- Net Profit Margin has improved marginally, moving from 2.29% to 2.32%.
- The estimate for the future P/E ratio has increased from 20.55x to 21.08x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.
